Press monitoring
Swimming microrobots deliver cancer-fighting drugs to metastatic lung tumors in mice
19.6.2024 | Press monitoring
Engineers at the University of California San Diego have developed microscopic robots, known as microrobots, capable of swimming through the lungs to deliver cancer-fighting medication directly to metastatic tumors. This approach has shown promise in mice, where it inhibited the growth and spread of tumors that had metastasized to the lungs,...
Edible batteries, sensors and actuators unlock robots designed to be eaten
17.6.2024 | Press monitoring
Scientists have already made edible robotic components. The next challenge is integrating them together to create an entire robot snack that could be used in a wide range of applications, from delivering healthcare to monitoring the environment. Imagine ordering drone delivery for your takeout, and then, after eating your food, you eat the...
Credit: foliat - Fotolia.com
Engineered plants produce human milk sugars that could lead to healthier baby formula
14.6.2024 | Press monitoring
Worldwide, a majority of babies – approximately 75% – drink infant formula in their first six months of life, either as a sole source of nutrition or as a supplement to breastfeeding. But while formula provides essential food for growing babies, it currently does not replicate the full nutritional profile of breast milk. That's in part because...
Credit: contrastwerkstatt - Fotolia.com
Research team uses CRISPR/Cas9 to alter photosynthesis for the first time
12.6.2024 | Press monitoring
A team from the Innovative Genomics Institute at the University of California, Berkeley (UCB) has produced an increase in gene expression in a food crop by changing its upstream regulatory DNA. While other studies have used CRISPR/Cas9 gene-editing to knock out or decrease the expression of genes, new research published in Science Advances is the...
Credit: Jezper - Fotolia.com
Nanoparticles reprogram mouse immune systems to cope with allergens
10.6.2024 | Press monitoring
Two doses of allergen-encapsulating nanoparticles delivered intravenously prevented anaphylaxis during a food allergy test in mice, according to a study led by University of Michigan researchers. The results, published in Advanced Healthcare Materials, offer a potential path to improving the ease of allergy immunotherapies in humans which...
Chimeric nanomicelles show promise as alternative treatment for solid tumors
7.6.2024 | Press monitoring
Cross-border scientific collaboration has developed an alternative for the treatment of solid tumors based on inhibition of the inflammatory tumor microenvironment (TME). Solid tumors are difficult to treat, partly owing to cells and substances in the TME that prevent drugs from penetrating and stop the patient's own immune system from combating...
New modified CRISPR protein can fit inside virus used for gene therapy
5.6.2024 | Press monitoring
Researchers have developed a novel version of a key CRISPR gene-editing protein that shows efficient editing activity and is small enough to be packaged within a non-pathogenic virus that can deliver it to target cells. Hongjian Wang and colleagues at Wuhan University, China, present these findings in the open-access journal PLOS Biology. Recent...
Credit: fotoliaxrender - Fotolia.com
Study reveals promising technology for sepsis treatment using functional magnetic nanoclusters
3.6.2024 | Press monitoring
A research team has introduced a novel technology capable of removing inflammation-triggering agents in extracorporeal blood. The team, led by Professors Joo Hun Kang and Jinmyoung Joo in the Department of Biomedical Engineering at UNIST, in collaboration with Professor Jae Hyuk Lee from Seoul National University Bundang Hospital, anticipates...
Credit: agsandrew - Fotolia.com
Breakthrough synapse-regenerating ALS pill moves to phase 2 human trials
31.5.2024 | Press monitoring
A pioneering once-a-day pill that regenerates nerve cell connections damaged by ALS has been FDA-approved for ongoing clinical trials. The drug is now being given to those with ALS and could be a watershed moment in the treatment of the fatal disease. Spinogenix, a clinical-stage biopharmaceutical company, has developed SPG302, a unique...
New antibiotic kills pathogenic bacteria, spares healthy gut microbes
29.5.2024 | Press monitoring
Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut. The drug, called lolamicin, also warded off secondary infections with Clostridioides difficile, a common and dangerous hospital-associated...
